A shot of advocacy

Here's the latest news: Trump to order unemployment payments if impasse persists Japan's Shionogi to launch 25-minute coronavirus test next month New Zealand's Jacinda Ardern launches re-election bid A shot of advocacy There it was, plain as day on the listing: Moderna Inc. planned to enroll some 30,000 people in a much-anticipated study of its promising Covid-19 vaccine candidate. As criteria for the trial spelled out, people living with HIV couldn't be among them. After a flurry of activism, though, Moderna backtracked, saying this week that it will now allow people with "controlled HIV who are not otherwise immunosuppressed." The biotech also said it had planned a separate study for people living with HIV. A similar shift appears to be in the works for vaccine research from Pfizer Inc. and BioNTech SE that excludes people living with HIV, hepatitis B and hepatitis C, according to a statement provided by Pfizer on Thursday. Moderna headquarters stands in Cambridge, Massachusetts Photographer: Adam Glanzman/Bloomberg Who is included in Covid-19 vaccine research today will have tremendous implications in the years to come, especially if the experimental candidates are successful. The stakes are especially high for populations already known to be at-risk or disproportionately affected by the new coronavirus, like elderly people, those with other medical conditions and people of color. But unlike so many other features of this public-health crisis, exclusionary clinical trials are hardly unprecedented in American medicine. There's a long tradition of highly organized HIV advocacy in the U.S., and it's a community that knows especially well the difference clinical trials can make. Will everyone get that kind of support?--Emma Court Listen up A Generation of Health Damage The coronavirus has been spreading worldwide for over seven months now, and more than 18 million people are known to have been infected by it. Over that time, we've come to understand that, in most people, the virus causes mild symptoms or none at all -- at least at the time they have the virus. But even asymptomatic patients may suffer lingering effects. Photographer: Patricia Suzara Photographer: Patricia Suzara   Sponsored Content by Siemens America's factories, power plants, transportation and hospitals all need technology and our technology is only as powerful as the people deploying and maintaining it. Keeping America moving takes more than technology alone. It takes a human touch. Siemens Ingenuity for life.   What you should read Tigers Still Need to Eat Lincolnshire Wildlife Park hasn't had many visitors lately. The Perfect Time to Get Work Done? Plastic surgery is booming when no one can see your whole face. Number of Kids Hospitalized Is Rising Children with Covid-19 are hospitalized infrequently. NFL Is Changing Its Testing Protocol Players who test positive will get two more confirmatory tests. Philippines Has Resources to Endure Virus The country has resources for a "protracted" fight against the pandemic. Know someone else who would like this newsletter?  Have them sign up here. Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story. Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close. Follow Us Get the newsletter You received this message because you are subscribed to Bloomberg's Coronavirus Daily newsletter. Unsubscribe | Bloomberg.com | Contact Us Bloomberg L.P. 731 Lexington, New York, NY, 10022